Association between OGG1 Ser326Cys and APEX1 Asp148Glu polymorphisms and breast cancer risk: a meta-analysis

Diagnostic Pathology

Shan Li¹  Xue Qin¹  Jingzhe Sui¹  Ruolin Li³  Zhiping Chen²  Xianjun Lao¹  Yu Lu¹  Qiliu Peng¹ 

[1] Department of Clinical Laboratory, First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi 530021, China;Department of Occupational Health and Environmental Health, School of Public Health at Guangxi Medical University, Nanning, Guangxi, China;Department of Medicine Research, First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China

关键词: Meta-analysis;    Polymorphism;    APE1;    OGG1;    Breast cancer;   

Others  :  801565
DOI  :  10.1186/1746-1596-9-108

 received in 2014-03-23, accepted in 2014-05-21,  发布年份 2014

【 摘 要 】

Background

The base excision repair (BER) pathway removes DNA damage caused by ionizing radiation, reactive oxidative species and methylating agents. OGG1 and APE1 are two important genes in the BER pathway. Many epidemiological studies have evaluated the association between polymorphisms in the two BER genes (OGG1 Ser326Cys and APE1 Asp148Glu) and breast cancer risk. However, the results are inconsistent.

Methods

We searched the electronic databases including PubMed, Embase and Cochrane library for all eligible studies for the period up to February 2014. Data were extracted by two independent authors and pooled odds ratios (ORs) with corresponding 95% confidence intervals (CIs) were used to assess the strength of the association.

Results

A total of 17 studies including 9,040 cases and 10,042 controls were available for OGG1 Ser326Cys polymorphism and 7 studies containing 2,979 cases and 3,111 controls were included for APE1 Asp148Glu polymorphism. With respect to OGG1 Ser326Cys polymorphism, we did not find a significant association with breast cancer risk when all eligible studies were pooled into the meta-analysis. However, in subgroup analyses by ethnicity and menopausal status, statistical significant increased breast cancer risk was found in Asian populations (Cys/Cys vs. Ser/Ser: OR = 1.157, 95% CI 1.013–1.321, P = 0.011; Cys/Cys vs. Ser/Cys + Ser/Ser: OR = 1.113, 95% CI 1.009–1.227, P = 0.014) and postmenopausal patients (Cys/Cys vs. Ser/Cys + Ser/Ser: OR = 1.162, 95% CI 1.003–1.346, P = 0.024). In subgroup analysis according to quality score, source of control, and HWE in controls, no any significant association was detected. With respect to APE1 Asp148Glu polymorphism, no significant association with breast cancer risk was demonstrated in the overall and stratified analyses.

Conclusions

The present meta-analysis suggests that the OGG1 Ser326Cys polymorphism may be a risk factor for breast cancer in Asians and postmenopausal patients. Further large and well-designed studies are needed to confirm this association.

Virtual Slides

The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/1156934297124915 webcite

【 授权许可】

   
2014 Peng et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

【 参考文献 】

• [1]Wang S, Li H, Wang J, Wang D: Expression of microRNA-497 and its prognostic significance in human breast cancer. Diagn Pathol 2013, 8:172. BioMed Central Full Text
• [2]Cheng H, Qin Y, Fan H, Su P, Zhang X, Zhang H, Zhou G: Overexpression of CARM1 in breast cancer is correlated with poorly characterized clinicopathologic parameters and molecular subtypes. Diagn Pathol 2013, 8:129. BioMed Central Full Text
• [3]El Fatemi H, Chahbouni S, Jayi S, Moumna K, Melhouf MA, Bannani A, Mesbahi O, Amarti A: Luminal B tumors are the most frequent molecular subtype in breast cancer of North African women: an immunohistochemical profile study from Morocco. Diagn Pathol 2012, 7:170. BioMed Central Full Text
• [4]Oger M, Allaoui M, Elie N, Marnay J, Herlin P, Plancoulaine B, Chasle J, Becette V, Bor-Angelier C: Impact of tumor heterogeneity on disease-free survival in a series of 368 patients treated for a breast cancer. Diagn Pathol 2013, 8:S43. BioMed Central Full Text
• [5]Wakeford R: The cancer epidemiology of radiation. Oncogene 2004, 23:6404-6428.
• [6]Ronckers CM, Erdmann CA, Land CE: Radiation and breast cancer: a review of current evidence. Breast Cancer Res 2005, 7:21-32. BioMed Central Full Text
• [7]Hoeijmakers JH: Genome maintenance mechanisms for preventing cancer. Nature 2001, 411:366-374.
• [8]Marnett LJ: Oxyradicals and DNA damage. Carcinogenesis 2000, 21:361-370.
• [9]Barzilai A, Yamamoto K: DNA damage responses to oxidative stress. DNA Repair (Amst) 2004, 3:1109-1115.
• [10]Hung RJ, Hall J, Brennan P, Boffetta P: Genetic polymorphisms in the base excision repair pathway and cancer risk: a HuGE review. Am J Epidemiol 2005, 162:925-942.
• [11]Izumi T, Hazra TK, Boldogh I, Tomkinson AE, Park MS, Ikeda S, Mitra S: Requirement for human AP endonuclease 1 for repair of 3'-blocking damage at DNA single-strand breaks induced by reactive oxygen species. Carcinogenesis 2000, 21:1329-1334.
• [12]Kelley MR, Cheng L, Foster R, Tritt R, Jiang J, Broshears J, Koch M: Elevated and altered expression of the multifunctional DNA base excision repair and redox enzyme Ape1/ref-1 in prostate cancer. Clin Cancer Res 2001, 7:824-830.
• [13]Park J, Chen L, Tockman MS, Elahi A, Lazarus P: The human 8-oxoguanine DNA N-glycosylase 1 (hOGG1) DNA repair enzyme and its association with lung cancer risk. Pharmacogenetics 2004, 14:103-109.
• [14]Lo YL, Jou YS, Hsiao CF, Chang GC, Tsai YH, Su WC, Chen KY, Chen YM, Huang MS, Hu CY, Chen CJ, Hsiung CA: A polymorphism in the APE1 gene promoter is associated with lung cancer risk. Cancer Epidemiol Biomarkers Prev 2009, 18:223-229.
• [15]Wu B, Liu HL, Zhang S, Dong XR, Wu G: Lack of an association between two BER gene polymorphisms and breast cancer risk: a meta-analysis. PLoS One 2012, 7:e50857.
• [16]Huang CS, Chen JJ, Yang SY, Cheng CW, Chern HD, Chang KJ, Wu PE, Shen CY: Breast Cancer Risk Associated with Genotypic Polymorphism of Oxidative DNA Damage Repair Genes - A Multigenic Study of Base Excision Repair and Transcription-Coupled Repair in Cancer Susceptibility. J Genet Mole Biol 2004, 15:116-136.
• [17]Kim KY, Han W, Noh DY, Kang D, Kwack K: Impact of genetic polymorphisms in base excision repair genes on the risk of breast cancer in a Korean population. Gene 2013, 532:192-196.
• [18]Gu D, Wang M, Zhang Z, Chen J: Lack of association between the hOGG1 Ser326Cys polymorphism and breast cancer risk: evidence from 11 case–control studies. Breast Cancer Res Treat 2010, 122:527-531.
• [19]Yuan W, Xu L, Feng Y, Yang Y, Chen W, Wang J, Pang D, Li D: The hOGG1 Ser326Cys polymorphism and breast cancer risk: a meta-analysis. Breast Cancer Res Treat 2010, 122:835-842.
• [20]Roberts MR, Shields PG, Ambrosone CB, Nie J, Marian C, Krishnan SS, Goerlitz DS, Modali R, Seddon M, Lehman T, Amend KL, Trevisan M, Edge SB, Freudenheim JL: Single-nucleotide polymorphisms in DNA repair genes and association with breast cancer risk in the web study. Carcinogenesis 2011, 32:1223-1230.
• [21]Xie H, Xia K, Rong H, Chen X: Genetic polymorphism in hOGG1 is associated with triple-negative breast cancer risk in Chinese Han women. Breast 2013, 22:707-712.
• [22]Smolarz B, Makowska M, Samulak D, Michalska MM, Mojs E, Wilczak M, Romanowicz H: Single nucleotide polymorphisms (SNPs) of ERCC2, hOGG1, and XRCC1 DNA repair genes and the risk of triple-negative breast cancer in Polish women. Tumour Biol 2014, 35:3495-3502.
• [23]Thakkinstian A, McEvoy M, Minelli C, Gibson P, Hancox B, Duffy D, Thompson J, Hall I, Kaufman J, Leung TF, Helms PJ, Hakonarson H, Halpi E, Navon R, Attia J: Systematic review and meta-analysis of the association between {beta}2-adrenoceptor polymorphisms and asthma: a HuGE review. Am J Epidemiol 2005, 162:201-211.
• [24]Higgins JP, Thompson SG: Quantifying heterogeneity in a meta-analysis. Stat Med 2002, 21:1539-1558.
• [25]Mantel N, Haenszel W: Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959, 22:719-748.
• [26]DerSimonian R, Laird N: Meta-analysis in clinical trials. Control Clin Trials 1986, 7:177-188.
• [27]Goode EL, Ulrich CM, Potter JD: Polymorphisms in DNA repair genes and associations with cancer risk. Cancer Epidemiol Biomarkers Prev 2002, 11:1513-1530.
• [28]Sterpone S, Mastellone V, Padua L, Novelli F, Patrono C, Cornetta T, Giammarino D, Donato V, Testa A, Cozzi R: Single-nucleotide polymorphisms in BER and HRR genes, XRCC1 haplotypes and breast cancer risk in Caucasian women. J Cancer Res Clin Oncol 2010, 136:631-636.
• [29]Sapkota Y, Mackey JR, Lai R, Franco-Villalobos C, Lupichuk S, Robson PJ, Kopciuk K, Cass CE, Yasui Y, Damaraju S: Assessing SNP-SNP interactions among DNA repair, modification and metabolism related pathway genes in breast cancer susceptibility. PLoS One 2013, 8:e64896.
• [30]Ali MF, Meza JL, Rogan EG, Chakravarti D: Prevalence of BER gene polymorphisms in sporadic breast cancer. Oncol Rep 2008, 19:1033-1038.
• [31]Vogel U, Nexo BA, Olsen A, Thomsen B, Jacobsen NR, Wallin H, Overvad K, Tjonneland A: No association between OGG1 Ser326Cys polymorphism and breast cancer risk. Cancer Epidemiol Biomarkers Prev 2003, 12:170-171.
• [32]Choi JY, Hamajima N, Tajima K, Yoo KY, Yoon KS, Park SK, Kim SU, Lee KM, Noh DY, Ahn SH, Choe KJ, Han W, Hirvonen A, Kang D: hOGG1 Ser326Cys polymorphism and breast cancer risk among Asian women. Breast Cancer Res Treat 2003, 79:59-62.
• [33]Zhang Y, Newcomb PA, Egan KM, Titus-Ernstoff L, Chanock S, Welch R, Brinton LA, Lissowska J, Bardin-Mikolajczak A, Peplonska B, Szeszenia-Dabrowska N, Zatonski W, Garcia-Closas M: Genetic polymorphisms in base-excision repair pathway genes and risk of breast cancer. Cancer Epidemiol Biomarkers Prev 2006, 15:353-358.
• [34]Rossner P Jr, Terry MB, Gammon MD, Zhang FF, Teitelbaum SL, Eng SM, Sagiv SK, Gaudet MM, Neugut AI, Santella RM: OGG1 polymorphisms and breast cancer risk. Cancer Epidemiol Biomarkers Prev 2006, 15:811-815.
• [35]Cai Q, Shu XO, Wen W, Courtney R, Dai Q, Gao YT, Zheng W: Functional Ser326Cys polymorphism in the hOGG1 gene is not associated with breast cancer risk. Cancer Epidemiol Biomarkers Prev 2006, 15:403-404.
• [36]Synowiec E, Stefanska J, Morawiec Z, Blasiak J, Wozniak K: Association between DNA damage, DNA repair genes variability and clinical characteristics in breast cancer patients. Mutat Res 2008, 648:65-72.
• [37]Sangrajrang S, Schmezer P, Burkholder I, Waas P, Boffetta P, Brennan P, Bartsch H, Wiangnon S, Popanda O: Polymorphisms in three base excision repair genes and breast cancer risk in Thai women. Breast Cancer Res Treat 2008, 111:279-288.
• [38]Romanowicz-Makowska H, Smolarz B, Makowski M, Polac I, Pertynski T: Ser326Cys polymorphism in DNA repair genes hOGG1 in breast cancer women. Pol J Pathol 2008, 59:201-204.
• [39]Loizidou MA, Michael T, Neuhausen SL, Newbold RF, Marcou Y, Kakouri E, Daniel M, Papadopoulos P, Malas S, Hadjisavvas A, Kyriacou K: DNA-repair genetic polymorphisms and risk of breast cancer in Cyprus. Breast Cancer Res Treat 2009, 115:623-627.
• [40]Sterpone S, Cornetta T, Padua L, Mastellone V, Giammarino D, Testa A, Tirindelli D, Cozzi R, Donato V: DNA repair capacity and acute radiotherapy adverse effects in Italian breast cancer patients. Mutat Res 2010, 684:43-48.
• [41]Ming-Shiean H, Yu JC, Wang HW, Chen ST, Hsiung CN, Ding SL, Wu PE, Shen CY, Cheng CW: Synergistic effects of polymorphisms in DNA repair genes and endogenous estrogen exposure on female breast cancer risk. Ann Surg Oncol 2010, 17:760-771.
• [42]Smith TR, Levine EA, Freimanis RI, Akman SA, Allen GO, Hoang KN, Liu-Mares W, Hu JJ: Polygenic model of DNA repair genetic polymorphisms in human breast cancer risk. Carcinogenesis 2008, 29:2132-2138.
• [43]Jelonek K, Gdowicz-Klosok A, Pietrowska M, Borkowska M, Korfanty J, Rzeszowska-Wolny J, Widlak P: Association between single-nucleotide polymorphisms of selected genes involved in the response to DNA damage and risk of colon, head and neck, and breast cancers in a Polish population. J Appl Genet 2010, 51:343-352.
• [44]Wood RD, Mitchell M, Sgouros J, Lindahl T: Human DNA repair genes. Science 2001, 291:1284-1289.
• [45]Zhang L, Zhang Z, Yan W: Single nucleotide polymorphisms for DNA repair genes in breast cancer patients. Clin Chim Acta 2005, 359:150-155.
• [46]Garcia-Closas M, Malats N, Real FX, Welch R, Kogevinas M, Chatterjee N, Pfeiffer R, Silverman D, Dosemeci M, Tardon A, Serra C, Carrato A, Garcia-Closas R, Castano-Vinyals G, Chanock S, Yeager M, Rothman N: Genetic variation in the nucleotide excision repair pathway and bladder cancer risk. Cancer Epidemiol Biomarkers Prev 2006, 15:536-542.
• [47]Roy D, Liehr JG: Estrogen, DNA damage and mutations. Mutat Res 1999, 424:107-115.
• [48]Yoshie Y, Ohshima H: Synergistic induction of DNA strand breakage by catechol-estrogen and nitric oxide: implications for hormonal carcinogenesis. Free Radic Biol Med 1998, 24:341-348.
• [49]Floyd RA: The role of 8-hydroxyguanine in carcinogenesis. Carcinogenesis 1990, 11:1447-1450.
• [50]Kohno T, Shinmura K, Tosaka M, Tani M, Kim SR, Sugimura H, Nohmi T, Kasai H, Yokota J: Genetic polymorphisms and alternative splicing of the hOGG1 gene, that is involved in the repair of 8-hydroxyguanine in damaged DNA. Oncogene 1998, 16:3219-3225.
• [51]Canbay E, Cakmakoglu B, Zeybek U, Sozen S, Cacina C, Gulluoglu M, Balik E, Bulut T, Yamaner S, Bugra D: Association of APE1 and hOGG1 polymorphisms with colorectal cancer risk in a Turkish population. Curr Med Res Opin 2011, 27:1295-1302.
• [52]Yuan T, Wei J, Luo J, Liu M, Deng S, Chen P: Polymorphisms of base-excision repair genes hOGG1 326cys and XRCC1 280His increase hepatocellular carcinoma risk. Dig Dis Sci 2012, 57:2451-2457.
• [53]Okasaka T, Matsuo K, Suzuki T, Ito H, Hosono S, Kawase T, Watanabe M, Yatabe Y, Hida T, Mitsudomi T, Tanaka H, Yokoi K, Tajima K: hOGG1 Ser326Cys polymorphism and risk of lung cancer by histological type. J Hum Genet 2009, 54:739-745.